Literature DB >> 20609350

Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.

Jianfei Qi1, Koh Nakayama, Robert D Cardiff, Alexander D Borowsky, Karen Kaul, Roy Williams, Stan Krajewski, Dan Mercola, Philip M Carpenter, David Bowtell, Ze'ev A Ronai.   

Abstract

Neuroendocrine (NE) phenotype, seen in >30% of prostate adenocarcinomas (PCa), and NE prostate tumors are implicated in aggressive prostate cancer. Formation of NE prostate tumors in the TRAMP mouse model was suppressed in mice lacking the ubiquitin ligase Siah2, which regulates HIF-1alpha availability. Cooperation between HIF-1alpha and FoxA2, a transcription factor expressed in NE tissue, promotes recruitment of p300 to transactivate select HIF-regulated genes, Hes6, Sox9, and Jmjd1a. These HIF-regulated genes are highly expressed in metastatic PCa and required for hypoxia-mediated NE phenotype, metastasis in PCa, and the formation of NE tumors. Tissue-specific expression of FoxA2 combined with Siah2-dependent HIF-1alpha availability enables a transcriptional program required for NE prostate tumor development and NE phenotype in PCa. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20609350      PMCID: PMC2919332          DOI: 10.1016/j.ccr.2010.05.024

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  47 in total

1.  A binding motif for Siah ubiquitin ligase.

Authors:  Colin M House; Ian J Frew; Huei-Luen Huang; Gerhard Wiche; Nadia Traficante; Edouard Nice; Bruno Catimel; David D L Bowtell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

2.  Generation and analysis of Siah2 mutant mice.

Authors:  Ian J Frew; Vicki E Hammond; Ross A Dickins; Julian M W Quinn; Carl R Walkley; Natalie A Sims; Ralf Schnall; Neil G Della; Andrew J Holloway; Matthew R Digby; Peter W Janes; David M Tarlinton; Louise E Purton; Matthew T Gillespie; David D L Bowtell
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.

Authors:  Xuehong Deng; Han Liu; Jiaoti Huang; Liang Cheng; Evan T Keller; Sarah J Parsons; Chang-Deng Hu
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

4.  Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.

Authors:  Zongxiang Zhou; Andrea Flesken-Nikitin; David C Corney; Wei Wang; David W Goodrich; Pradip Roy-Burman; Alexander Yu Nikitin
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

5.  An essential role for p300/CBP in the cellular response to hypoxia.

Authors:  Z Arany; L E Huang; R Eckner; S Bhattacharya; C Jiang; M A Goldberg; H F Bunn; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.

Authors:  Lawryn H Kasper; Fayçal Boussouar; Kelli Boyd; Wu Xu; Michelle Biesen; Jerold Rehg; Troy A Baudino; John L Cleveland; Paul K Brindle
Journal:  EMBO J       Date:  2005-10-20       Impact factor: 11.598

7.  Hes6 controls cell proliferation via interaction with cAMP-response element-binding protein-binding protein in the promyelocytic leukemia nuclear body.

Authors:  Bokkee Eun; Yool Lee; Soontaek Hong; Jaesang Kim; Han-Woong Lee; Kyungjin Kim; Woong Sun; Hyun Kim
Journal:  J Biol Chem       Date:  2007-12-26       Impact factor: 5.157

Review 8.  Neuroendocrine differentiation in prostate cancer: from lab to bedside.

Authors:  Luca Cindolo; Monica Cantile; Francis Vacherot; Stéphane Terry; Alexandre de la Taille
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

Review 9.  Oxygen sensors at the crossroad of metabolism.

Authors:  Julián Aragonés; Peter Fraisl; Myriam Baes; Peter Carmeliet
Journal:  Cell Metab       Date:  2009-01-07       Impact factor: 27.287

10.  Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth.

Authors:  Atique U Ahmed; Rebecca L Schmidt; Cheol Hong Park; Nanette R Reed; Shayla E Hesse; Charles F Thomas; Julian R Molina; Claude Deschamps; Ping Yang; Marie C Aubry; Amy H Tang
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

View more
  115 in total

Review 1.  Molecular mechanisms and potential functions of histone demethylases.

Authors:  Susanne Marije Kooistra; Kristian Helin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

2.  Ubiquitin ligase Siah2 regulates RevErbα degradation and the mammalian circadian clock.

Authors:  Jason P DeBruyne; Julie E Baggs; Trey K Sato; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

3.  The ubiquitin ligase Siah2 is revealed as an accomplice of the androgen receptor in castration resistant prostate cancer.

Authors:  Michael R Freeman
Journal:  Asian J Androl       Date:  2013-05-27       Impact factor: 3.285

Review 4.  Mouse models of prostate cancer: picking the best model for the question.

Authors:  Magdalena M Grabowska; David J DeGraff; Xiuping Yu; Ren Jie Jin; Zhenbang Chen; Alexander D Borowsky; Robert J Matusik
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

5.  Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6).

Authors:  Michaeline L Hebron; Irina Lonskaya; Kaydee Sharpe; Puwakdandawe P K Weerasinghe; Norah K Algarzae; Ashot R Shekoyan; Charbel E-H Moussa
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

Review 6.  Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.

Authors:  William Hankey; Zhong Chen; Qianben Wang
Journal:  Cancer Res       Date:  2020-02-24       Impact factor: 12.701

7.  Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells.

Authors:  X-B Shi; L Xue; A-H Ma; C G Tepper; R Gandour-Edwards; H-J Kung; R W deVere White
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

8.  Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2.

Authors:  Aparna Gupta; Xiuping Yu; Tom Case; Manik Paul; Michael M Shen; Klaus H Kaestner; Robert J Matusik
Journal:  Prostate       Date:  2012-10-11       Impact factor: 4.104

9.  Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.

Authors:  Haiyan Yang; Zhenguo Liu; Cuncun Yuan; Yunfei Zhao; Lei Wang; Jiong Hu; Dacheng Xie; Liwei Wang; Donghui Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.

Authors:  Michael Ittmann; Jiaoti Huang; Enrico Radaelli; Philip Martin; Sabina Signoretti; Ruth Sullivan; Brian W Simons; Jerrold M Ward; Brian D Robinson; Gerald C Chu; Massimo Loda; George Thomas; Alexander Borowsky; Robert D Cardiff
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.